Keywords: DWI/DTI/DKI, Brain, Glymphatic system
Motivation: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that primarily affects the brain and leads to diffusion impairment.
Goal(s): To evaluate the alterations of glymphatic function in AD and explore its association with cognition and blood biomarkers.
Approach: We investigate the functionality of glymphatic system (GS) in patients with AD using diffusion tensor imaging analysis along with the perivascular space (DTI-ALPS).
Results: Individuals with AD had a significantly lower ALPS index compared to the healthy controls. Moreover, the decreased ALPS index was associated with impaired cognitive function, as reflected through the Mini-Mental State Examination (MMSE) score and higher blood biomarker ptau-181 levels.
Impact: The results demonstrate that the feasibility of DTI-ALPS, which can be used for research on glymphatic system function in AD patients. ALPS-index is expected to become a promising imaging marker and may provide novel targets for clinical diagnosis of AD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords